Postes actifs de Chulho Park
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Directeur Technique/Scientifique/R&D | 01/01/2015 | - |
| Fondateur | 01/01/2015 | - |
Historique de carrière de Chulho Park
Anciens postes connus de Chulho Park
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 22/04/2019 | 01/07/2021 |
| Mabprex, Inc. | Directeur Général | 01/01/2010 | 01/01/2018 |
| Fondateur | 01/01/2010 | 01/01/2018 | |
IgDraSol, Inc.
 IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Corporate Officer/Principal | 01/01/2013 | 01/09/2013 |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Health Technology |
IgDraSol, Inc.
IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Health Technology |
| Mabprex, Inc. |
- Bourse
- Insiders
- Chulho Park
- Expérience
